Amn healthcare services, inc. (AMN)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11
Cash flows from operating activities:
Net Income (Loss) Attributable to Parent

12,965

27,482

23,515

28,869

34,122

35,613

27,918

35,529

42,681

41,167

28,128

31,255

32,008

26,351

27,296

26,322

25,869

20,165

33,647

15,870

12,209

9,895

8,499

7,193

7,630

8,356

8,615

8,399

7,563

7,083

5,858

-81

4,276

-2,435

-26,899

813

2,256

Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization

20,234

17,007

17,085

12,718

11,710

11,449

11,296

10,606

7,886

8,520

8,132

7,959

7,668

7,732

7,789

7,334

6,765

5,322

5,304

5,232

5,095

4,077

4,086

4,010

3,820

-

3,317

3,240

3,290

-

-

-

-

-

-

-

-

Depreciation and amortization

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,552

3,695

-

-

-

4,465

Non-cash interest expense and other

1,911

-3,800

682

591

543

4,250

-686

677

600

-3,949

597

542

579

1,236

455

149

576

489

454

534

457

288

428

381

295

286

374

381

295

575

801

393

1,152

958

967

926

936

Change in fair value of contingent consideration

200

4,895

4,441

-1,458

-700

-1,093

-1,326

19

0

118

20

23

23

64

-302

115

99

-30

-300

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Increase in allowance for credit losses and sales credits

4,735

-

-

-

2,608

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Increase in allowances for doubtful accounts and sales credits

-

-

-

-

-

2,766

1,431

2,552

2,257

1,327

1,272

2,332

5,408

5,262

1,294

2,765

2,687

1,369

1,240

1,883

2,192

1,478

762

1,710

443

1,949

1,031

546

1,102

1,484

1,849

1,447

2,006

1,447

935

945

1,084

Provision for deferred income taxes

733

4,613

6,628

-1,292

-9,036

1,717

4,789

-2,060

-5,113

15,119

-488

-4,124

-4,900

-6,215

-2,790

782

-1,201

-5,006

11,454

870

5,359

10,011

2,842

-2,959

1,885

1,080

1,089

-161

1,023

2,504

3,120

-1,733

3,060

-1,100

-1,230

-803

1,338

Share-based Payment Arrangement, Noncash Expense

4,927

4,528

2,825

3,702

5,186

2,861

1,809

3,281

2,864

2,517

2,477

2,562

2,681

2,604

2,704

2,710

3,381

3,733

2,021

2,153

2,377

1,796

1,791

1,751

1,819

-

1,487

1,478

1,702

-

-

-

-

-

1,697

1,723

1,989

Share-based compensation

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,646

1,569

1,577

1,432

-

-

-

-

Excess tax benefit from equity awards vested and exercised

-

-

-

-

-

-

-

-

-

-

-

-

-

587

0

442

2,322

180

458

1,782

5,029

39

64

170

1,546

-8

98

727

704

32

1

5

6

1

14

93

1

Gain on sale of discontinued operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

1,187

0

0

0

0

Loss on disposal or sale of fixed assets

-3,266

-35

-410

-35

-4

-77

-1

-34

-5

-97

-87

22

-65

-24

-22

-23

0

-1

-3

-2

2

-10

-46

-3

-1

-1

-5

0

-8

-16

-2

-14

0

-8

-27

-28

-45

Write-off of fees on credit facilities

-

-

-

-

-

0

0

0

-574

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of discount on investments

50

22

47

109

120

124

16

47

15

15

70

42

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net gain on deferred compensation balances

240

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Non-cash lease expense

179

-6

-105

14

92

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Changes in assets and liabilities, net of effects from acquisitions:
Accounts receivable

5,786

-3,132

-12,719

-13,927

1,500

2,196

13,087

-4,676

-9,154

8,227

10,271

2,147

-1,787

16,106

1,160

26,215

15,219

28,921

19,393

10,896

16,443

22,442

13,335

2,375

3,806

3,542

-3,834

-6,406

15,342

2,113

7,195

-3,633

-3,033

4,163

5,919

2,265

11,254

Accounts receivable, subcontractor

3,224

9,961

12,694

-5,549

5,465

5,252

10,234

-4,370

-1,985

3,812

569

-12,207

-395

7,139

-4,233

-3,532

-916

1,287

12,612

2,718

5,748

6,874

-943

3,832

409

-598

3,141

-3,604

865

-1,219

-2,310

-1,344

843

5,056

1,739

-2,638

1,258

Income taxes receivable

-5,984

1,063

1,728

2,472

-799

-2,102

989

-4,105

-9,881

13,683

1,029

1,186

-361

-309

-712

558

-6,006

-6,859

4,195

-32

-5,171

-284

1,595

1,035

-3,114

-

-

-

-

-

-

-

-

1,162

196

-1,257

-489

Prepaid expenses

7,663

344

-2,641

-3,864

5,387

-2,131

-4,346

-363

2,375

673

-1,321

-2,345

5,309

260

-1,818

-456

2,469

702

-484

-45

2,742

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other current assets

-3,463

-1,515

-749

-2,366

1,783

1,705

-1,059

3,438

-2,825

1,799

-4,744

-1,090

-266

-4,447

2,719

5,913

1,477

-702

487

5,303

321

-2,653

-2,348

-987

4,068

1,322

-1,720

-5,897

2,436

5,828

-164

-2,247

5,267

445

-898

-1,447

2,725

Other assets

-2,409

3,961

27

2,561

6,202

-6,258

1,575

-645

89

202

-559

2,624

3,139

-733

253

1,571

2,471

1,331

761

543

2,150

80

134

-552

606

9,385

159

1,194

1,127

-567

1,247

-520

1,377

115

-271

251

152

Accounts payable and accrued expenses

15,836

16,202

15,194

-32,420

2,949

9,843

16,265

-1,138

-7,816

12,580

-1,927

-16,916

-1,599

18,496

-13,356

22,794

-10,229

3,803

11,746

10,441

3,621

10,427

1,844

44

-6,190

4,671

1,246

-3,775

4,102

5,542

-7,147

-683

1,608

2,657

4,250

-3,752

505

Accrued compensation and benefits

-2,031

12,971

8,013

11,444

330

-762

5,546

9,475

-4,007

9,439

4,701

7,641

-8,351

8,381

-2,887

3,873

9,775

-4,819

11,367

4,344

996

2,890

8,529

-912

1,008

1,589

7,350

-2,522

-50

11,391

-6,223

558

68

595

-2,412

152

7,700

Other liabilities

-6,894

1,183

-1,421

-15,482

9,630

1,443

-3,835

-5,090

-1,498

-3,330

-5,637

-16,300

16,825

2,411

4,117

-12,460

14,079

2,262

-13,163

4,416

4,382

-9,150

3,538

755

369

9,746

1,497

2,665

-779

-3,704

-1,771

4,543

-2,097

1,453

-907

-2,014

-2,369

Deferred revenue

748

232

-13

-607

-1,418

-743

-511

1,625

-52

-1,226

-38

800

-84

476

2,299

-2,329

286

173

-674

2,346

-532

-77

-60

43

-20

-

-

-

-

-

-

-

-

-

-

-

-

Restricted cash, cash equivalents and investments balance

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,926

205

-36

3,081

3,082

2,875

1,076

1,075

2,150

0

-

-

-

-

-

-

-

-

Restricted investments balance

-21

21

-6

-57

-36

6

93

-19

12

8

-44

36

0

-870

-268

1,314

-176

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by operating activities

51,365

78,657

80,914

29,077

36,214

58,947

42,108

66,203

59,735

58,422

32,053

25,359

44,684

49,089

29,540

20,053

35,227

676

21,950

25,000

8,687

5,185

15,452

6,177

864

15,820

27,092

19,475

-2,218

16,318

11,512

20,997

9,553

6,513

4,881

2,354

5,564

Cash flows from investing activities:
Purchase and development of fixed assets

13,571

10,442

9,244

8,144

7,388

11,284

7,465

10,754

5,703

9,361

5,427

6,243

5,498

4,251

4,811

6,276

6,618

5,888

6,518

8,234

6,370

4,847

4,411

4,033

5,843

2,600

1,099

3,133

2,215

1,719

1,543

1,209

1,001

1,098

1,099

764

1,687

Purchase of investments

4,479

9,550

3,478

5,919

7,362

6,639

20,443

4,656

2,086

4,075

3,770

2,447

4,804

13,152

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from maturity of investments

9,600

3,500

5,965

10,970

11,700

14,600

2,200

5,300

2,900

3,101

9,000

6,200

2,000

2,000

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in restricted cash, cash equivalents and investments balance

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-1,409

-2,675

-4,117

-4,349

1

3

9

-60

-56

582

94

-3

-6

8

-2,719

0

Equity investment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

2,000

1,000

2,000

0

0

0

0

-

-

-

-

-

-

-

-

Loan to Pipeline Health Holdings LLC

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

333

667

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Payments to fund deferred compensation plan

5,471

1,143

6,085

1,696

3,583

2,117

3,076

0

4,724

481

3,232

1,826

4,998

1,246

2,603

207

2,855

754

98

949

1,203

0

775

184

1,215

47

516

254

481

-

-

-

-

-

-

-

-

Purchase of convertible promissory note

490

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payments to Acquire Businesses, Gross

476,392

-

-

-

29,525

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cash paid for other intangibles

1,400

120

0

1,030

90

0

0

1,180

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cash received for working capital adjustments for prior year acquisitions

66

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payments for Previous Acquisition

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

825

0

0

165

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from sales of assets held for sale

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

406

22

272

8,350

0

0

0

0

Net cash used in investing activities

-492,137

-38,218

-12,915

-204,443

-36,248

-7,689

-32,698

-229,337

-9,613

-11,316

-4,429

-6,316

-13,300

-17,090

-8,117

-58,451

-174,703

-10,451

-10,768

-9,516

-85,350

-17,908

-4,511

-1,100

-4,709

-42,148

-1,018

-3,396

-2,636

-2,640

-2,103

-1,031

7,352

-1,142

-1,107

1,955

-1,687

Cash flows from financing activities:
Capital lease repayments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

4

57

159

157

156

202

161

160

158

158

162

162

168

170

169

168

166

Payments on term loans

-

-

-

-

-

-

-

-

-

0

18,125

25,000

938

159,375

2,813

2,812

2,813

1,875

1,875

1,875

1,875

1,875

1,875

151,495

0

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from term loans

250,000

0

0

150,000

0

-

-

-

-

-

-

-

-

0

0

0

75,000

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Repayments of Lines of Credit

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-2,000

10,000

10,000

7,000

0

6,500

32,000

1,000

15,000

1,000

0

0

6,000

0

0

-3,000

-5,300

-11,600

0

0

Proceeds from prior revolving credit facility

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

1,000

-

0

0

0

-

-

-

-

Proceeds from revolving credit facility

225,000

0

0

71,000

30,000

0

0

195,000

0

-

-

-

-

0

0

39,000

85,000

5,000

0

0

84,500

18,000

0

28,500

1,000

-

-

-

-

-

-

-

-

-

-

-

2,300

Repurchase of common stock

0

0

0

775

17,930

14,263

31,859

20,891

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payment of financing costs

3,899

4,348

98

777

0

0

0

0

2,331

0

0

0

0

6,113

0

0

448

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Earn-out payments for prior acquisitions

10,622

0

0

5,700

0

0

0

0

1,713

0

0

0

3,677

0

0

0

900

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Repayments of prior notes payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

196,685

9,815

4,625

4,625

2,312

2,313

Proceeds from exercise of equity awards

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

310

154

3,199

0

1,734

0

58

3

407

56

711

530

0

0

0

-

-

-

-

Cash paid for shares withheld for taxes

4,353

431

1,809

1,253

10,280

0

24

482

10,926

302

58

1,701

7,313

227

0

360

5,194

395

195

2,624

8,694

87

118

338

3,905

8

125

1,134

1,403

203

29

187

656

12

41

1,271

734

Excess tax benefit from equity awards vested and exercised

-

-

-

-

-

-

-

-

-

-

-

-

-

587

0

442

2,322

180

458

1,782

5,029

39

64

170

1,546

-8

98

727

704

32

1

5

6

1

14

93

1

Change in bank overdraft

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-75

-25

165

-

3,201

-895

-2,290

-1,264

589

640

-913

Net cash provided by financing activities

456,126

159

-52,845

187,495

1,790

-44,263

-36,883

133,627

-14,970

-13,369

-24,951

-26,945

-11,928

-36,128

-26,817

36,268

152,967

4,910

-11,302

-12,563

75,155

16,020

-6,854

-8,808

-2,457

10,291

-4,856

-7,471

1,019

-11,815

-21,029

-9,402

-15,923

-6,070

-7,087

-318

-1,825

Effect of exchange rate changes on cash

-47

59

132

-89

-101

58

133

91

-19

13

-73

-42

4

102

40

86

39

33

54

-80

68

113

75

-37

-9

-36

-84

-28

93

-5

-55

33

-43

18

32

-1

-1

Net increase in cash, cash equivalents and restricted cash

15,307

40,657

15,286

12,040

1,655

7,053

-27,340

-29,416

35,133

33,750

2,600

-7,944

19,460

-4,027

-5,354

-2,044

13,530

-4,832

-66

2,841

-1,440

3,410

4,162

-3,768

-6,311

-16,073

21,134

8,580

-3,742

1,858

-11,675

10,597

939

-681

-3,281

3,990

2,051

Supplemental disclosures of cash flow information:
Cash paid for amounts included in the measurement of operating lease liabilities

4,734

4,523

4,600

4,356

4,338

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cash paid for interest (net of $159 and $102 capitalized for the three months ended March 31, 2020 and 2019, respectively)

1,898

8,742

3,274

10,190

1,524

9,762

1,354

9,966

201

8,541

266

8,584

545

951

2,428

2,383

2,295

1,472

1,598

1,406

1,330

912

927

1,172

1,588

3,152

20

1,834

2,399

2,706

2,925

3,547

4,520

4,156

6,378

4,507

4,626

Cash paid for income taxes

45

5,290

5,088

23,177

4,192

9,370

6,818

11,674

2,731

7,748

20,834

42,352

2,812

20,682

18,574

31,692

2,418

12,477

13,273

6,909

473

5,148

3,562

8,947

223

4,157

5,363

4,469

4,876

1,497

49

198

116

-1,118

335

835

336

Business Combinations [Abstract]
Acquisitions:
Fair value of tangible assets acquired in acquisitions, net of cash and restricted cash received

37,240

1,118

868

26,633

1,041

-1

450

23,577

0

-

-

-

-

-86

613

5,470

12,706

431

728

-15

25,627

1,631

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Goodwill

255,974

8,941

-1,846

123,447

26,494

207

-835

98,538

0

-

-

-

-

-420

-653

35,643

101,531

3,336

4,118

71

42,702

9,750

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Intangible assets

252,000

9,000

2,400

89,300

6,880

-1

1

122,110

0

-

-

-

-

0

-20

19,240

69,844

645

3,373

0

30,219

9,960

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Liabilities assumed

68,822

-3,725

1,349

30,134

3,390

206

302

16,078

0

-

-

-

-

-447

29

8,753

13,139

428

867

56

21,603

3,821

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Holdback provision

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-292

0

2,122

1,000

500

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Earn-out liabilities

0

3,100

0

10,622

1,500

0

0

10,100

0

-

-

-

-

0

0

480

3,590

0

2,700

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash paid for acquisitions

476,392

19,684

73

198,624

29,525

-1

-686

218,047

0

-

-

-

-

-59

203

51,120

165,230

2,984

4,152

0

76,945

14,470

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Supplemental disclosures of non-cash investing and financing activities:
Purchase of fixed assets recorded in accounts payable and accrued expenses

1,786

159

-210

-214

2,566

-2,798

2,704

-1,060

2,860

-194

917

-201

2,440

764

-350

-769

2,489

1,131

-400

-1,001

3,607

867

597

87

3,067

-

-

-

-

-

-

-

-

-

-

-

-